U.S. Markets open in 37 hrs, 55 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.00 10:20 AM EDT | |
|---|---|---|
| Day High | 1.07 09:33 AM EDT |
|
| Range | 0.07 |
| Volume | 157,394 | |
|---|---|---|
| 30-Day Avg Vol | 777,000 |
|
| Difference | -79.74% |
| Market Cap | 20.63 M | |
|---|---|---|
| Mkt Cap Chg | -817,325 |
| Shares Out | 20.43 M | |
|---|---|---|
| % Shrs Traded | 0.77% | |
| 1yr EPS Est | -1.025 |
| 52-Wk Low | 0.23 11/19/08 | |
|---|---|---|
| 52-Wk High | 1.99 8/27/08 |
|
| Range | 1.76 |
| Prev Close | 1.05 7/1/09 | |
|---|---|---|
| Today's Open | 1.05 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 41,564.00 |
| Revenue (LFY) | 877,000 | |
|---|---|---|
| Earnings (LFY) | -40.39 M | |
| Earnings (MRQ) | -5.06 M | |
| Next Earn Est | -0.255 | |
| Next Earnings | 08/03/2009 |
|
| EPS (TTM) | -1.92 | |
| 1yr EPS Growth | 46.61% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 0.00 | |
| PEG Ratio | — | |
| Return on Equity | -217.14 | |
| Beta | 2.68 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cyclacel has found a new reason to be excited. Formerly Xcyte Therapies, the company acquired Cyclacel Group in a reverse merger early in 2006. As part of the transaction, Xcyte sold its primary technology ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.255 8/3/09 | — — |
—
—
|
| Last Quarter | -0.295 3/31/09 | -0.25 3/31/09 |
0.045
Beat
|
| 2 Quarters Ago | -0.29 12/31/08 | -0.39 12/31/08 |
-0.10
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 228,000.00 | 877,000.00 |
| Gross Profit | -74,000.00 | -1.41 M |
| Operating Income | -5.22 M | -33.78 M |
| Net Income | -5.06 M | -40.39 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts